Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.4M
-
Number of holders
-
165
-
Total 13F shares, excl. options
-
29.2M
-
Shares change
-
+834K
-
Total reported value, excl. options
-
$679M
-
Value change
-
+$19.6M
-
Number of buys
-
88
-
Number of sells
-
-55
-
Price
-
$23.29
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q4 2021
172 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q4 2021.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 165 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.2M shares
of 46.4M outstanding shares and own 62.9% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.16M shares), FEDERATED HERMES, INC. (3.46M shares), VANGUARD GROUP INC (2.47M shares), DIMENSIONAL FUND ADVISORS LP (1.77M shares), STATE STREET CORP (1.44M shares), JANUS HENDERSON GROUP PLC (973K shares), GEODE CAPITAL MANAGEMENT, LLC (715K shares), Invesco Ltd. (697K shares), MORGAN STANLEY (619K shares), and FULLER & THALER ASSET MANAGEMENT, INC. (611K shares).
This table shows the top 165 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.